BREAKTHROUGHS IN RECOMBINANT HUMAN SERUM ALBUMIN FOR BIOPHARMACEUTICAL PROGRAMS

Recombinant human serum albumin (OsrHSA) has emerged as a significant innovation in the field of biopharmaceuticals, offering promising improvements across a variety of health care and industrial purposes. With its structural similarity to Obviously derived human serum albumin, OsrHSA delivers a safer, much more reliable alternate for therapeutic u